Daily Hand-Held Vibration Therapy for the Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN): A Pilot Study
Erin Newton, MD
Primary Investigator
Brief description of study
What is the purpose of this study?
The purpose of this study is to test a potential treatment for nerve damage (neuropathy) caused by chemotherapy.
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office
Email: iutrials@iu.edu
Phone: (317) 278-5632
Detailed description of study
What will happen during the study?
- Researchers will review medical records and collect demographic information to screen for eligibility.
- If eligible, participants will complete a baseline visit, completing questionnaires and receiving a small hand massager and instructions on how to perform hand vibration therapy during the study.
- Participants will perform hand-held vibration therapy every day for 4 weeks at home for 3 minutes on each hand. Participants will record information about their therapy, complete daily online surveys, and additional surveys once per week.
- After 4 weeks, participants will return the hand massager and answer questions about their neuropathy symptoms, quality of life, and satisfaction with the therapy.
- For a follow-up period of 4 weeks, participants will complete weekly surveys. Participants will finish with a final visit in which they will receive the hand massager again to keep.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Chemotherapy Induced Peripheral Neuropathy, CIPN
-
Age: 18 years - 100 years
-
Gender: All
Inclusion criteria
- Individuals at least 18 years of age who are experiencing neuropathy associated with chemotherapy (CIPN).
Exclusion criteria
- Individuals with pre-existing neuropathy not related to chemotherapy or diabetes will not be eligible.
